The Patent Finder

Azevan Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Azevan Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.

Showing 1 to 5 of 5 · Back to Azevan Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 9,987,265Methods for treating post traumatic stress disorder
Lapsed on the fee record
Ended Jun 5, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jun 5, 2026From the USPTO record
US 8,426,400β-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
Lapsed on the fee record
Ended Apr 23, 2025 · From the USPTO record
Lapsed on the fee recordEnded Apr 23, 2025From the USPTO record
US 9,597,314Beta-lactamylalkanoic acids for treating premenstrual disorders
Lapsed on the fee record
Ended Mar 21, 2025 · From the USPTO record
Lapsed on the fee recordEnded Mar 21, 2025From the USPTO record
US 7,119,083β-Lactamyl vasopressin V1a Antagonists
Term ended
Term ended Oct 11, 2022 · From the USPTO record
Term endedTerm ended Oct 11, 2022From the USPTO record
US 7,268,125β-lactamyl vasopressin V1a antagonists
Formerly held
Term ended
Term ended Oct 11, 2022 · From the USPTO record
Term endedTerm ended Oct 11, 2022From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited